| |
|
|
|
|
|
|
|
EP Extension Details
|
|
|
|
|
Extension ID
|
|
Extension Details
|
|
Extension ID:
|
20560_2
|
Date Submitted:
|
12/16/2021
|
|
|
Current EP Expiration Date:
|
02/28/2022
|
|
Extension Length:
|
6 months
|
|
Extension Expiration Date:
|
08/10/22
|
|
Estimated Amount:
|
$40,000,000.00
|
|
Change in Circumstances:
|
The Amendment is necessary for AMI to provide administration of monoclonal antibody infusion therapy services pursuant to the Master Services Agreement, while also serving to extend the term of the Original Agreement to provide COVID-19 vaccines and monoclonal antibody infusion therapy.
|
|
Justification for Extension:
|
COVID -19 pandemic.
|
|
Result, if not Approved:
|
COVID continues to spread across the Commonwealth. This EP extension provides the continuation of effective distribution of the vaccine which is critical to combat the spread of COVID in addition to the administration of monoclonal antibody infusion therapy services.
|
| |
|
Approval Status:
|
Approved
12/16/2021
|
|
Comments:
|
|
|
|
|
|
|
|
|